Medicine
Qlosi 4 mg/mL ophthalmic solution
Qlosi 4 mg/mL ophthalmic solution is a prescription medicine containing Pilocarpine for ophthalmic use, marketed by Orasis Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store refrigerated at 36°F to 46°F (2°C to 8°C). Once a pouch is open, the…
Key facts
- Active ingredient (INN)
- Pilocarpine
- Brand
- Qlosi
- Strength
- 4 mg/mL
- Dosage form
- Ophthalmic solution
- Route
- Ophthalmic
- Packs
- 10 vials, 20 vials, 30 vials and 1 more
- Marketing authorisation holder
- Orasis Pharmaceuticals
- Manufacturer
- Orasis Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store refrigerated at 36°F to 46°F (2°C to 8°C). Once a pouch is open, the single-patient-use vials may be stored at room temperature [up to 77°F (25°C)] and used within 30 days. Store unused product away from light.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N07AX01 Pilocarpine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 October 2024
- Identifiers
- RxCUI 2695439, 2695445DailyMed set ID 4ee2a840-1203-473a-aa42-316a3ddf2fbeNDC 83661-018Application NDA217836
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-use in 1 box / .4 mL in 1 vial, single-use | 83661-018-10 | Orasis Pharmaceuticals | 15 January 2025 |
| 20 vial, single-use in 1 box / .4 mL in 1 vial, single-use | 83661-018-20 | Orasis Pharmaceuticals | 15 January 2025 |
| 30 vial, single-use in 1 box / .4 mL in 1 vial, single-use | 83661-018-30 | Orasis Pharmaceuticals | 15 October 2024 |
| 60 vial, single-use in 1 box / .4 mL in 1 vial, single-use | 83661-018-60 | Orasis Pharmaceuticals | 15 January 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 July 1974 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Pilocarpine
Clinical summary
Pilocarpine is a cholinergic receptor agonist. It is available as tablets, eye drops and ophthalmic solution for oral use. MedsAcross supplies Pilocarpine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PilocarpineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Salagen prescribing information (Advanz Pharma) · U.S. National Library of Medicine, DailyMed
Need Qlosi 4 mg/mL ophthalmic solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.